Quam Securities

Since its inception in 1986, Quam Securities Limited (Quam Securities) has grown to become one of the few mid-tier securities brokerages in Hong Kong with global execution capabilities for both private and institutional clients. It boasts a well-established network in Greater China including Taiwan and in major world markets through the Global Alliance Partners (GAP). Quam Securities is well-positioned not only to harness and drive business within the China Tonghai International Financial Limited but also between China and the world markets.

Research from Quam Securities

Research from Quam Securities, Quam Securities

Quam Securities Research

Equity Bottom-Up

<ul><li>Hong Kong market commentary</li><li>A-share market commentary</li><li>Innovent entered into a strategic global licensing and collaboration agreement with Pfizer for up to US$10.5bn</li></ul>

Hong Kong market commentaryA-share market commentaryInnovent entered into a strategic global licensing and collaboration agreement with Pfizer for up to US$10.5bn

Innovent Biologics

Quam Morning Note (29 May) - Innovent